Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Michael Douglas Taylor. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Veja os Insiders com Maior Classificação
Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Michael Douglas Taylor reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:DCPH / Deciphera Pharmaceuticals, Inc. Director 193,752
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Michael Douglas Taylor. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Michael Douglas Taylor conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual		 Preço
da Ação		 Valor
da Transação		 Valor
Restante
2021-05-05 2021-05-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -5,646 193,752 -2.83
2021-05-05 2021-05-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -2,354 0 -100.00
2021-05-05 2021-05-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -300 0 -100.00 46.75 -14,025
2021-05-05 2021-05-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,700 300 -96.25 46.07 -354,718 13,820
2021-05-05 2021-05-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 5,646 8,000 239.85 3.95 22,302 31,600
2021-05-05 2021-05-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,354 2,354 1.89 4,449 4,449
2021-04-06 2021-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -8,000 2,354 -77.26
2021-04-06 2021-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -906 0 -100.00 46.72 -42,328
2021-04-06 2021-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,994 906 -84.64 45.69 -228,169 41,394
2021-04-06 2021-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,100 5,900 -26.25 44.80 -94,074 264,304
2021-04-06 2021-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 8,000 8,000 1.89 15,120 15,120
2021-03-03 2021-03-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -8,000 10,354 -43.59
2021-03-03 2021-03-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,104 0 -100.00 44.68 -49,324
2021-03-03 2021-03-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,896 1,104 -86.20 43.94 -302,983 48,505
2021-03-03 2021-03-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 8,000 8,000 1.89 15,120 15,120
2021-02-03 2021-02-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -8,000 18,354 -30.36
2021-02-03 2021-02-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -800 0 -100.00 45.96 -36,770
2021-02-03 2021-02-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,518 800 -84.96 45.64 -206,188 36,510
2021-02-03 2021-02-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,682 5,318 -33.52 44.34 -118,915 235,790
2021-02-03 2021-02-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 8,000 8,000 1.89 15,120 15,120
2021-01-06 2021-01-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -19,000 26,354 -41.89
2021-01-06 2021-01-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,794 0 -100.00 57.37 -160,294
2021-01-06 2021-01-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,517 2,794 -75.30 56.73 -483,175 158,505
2021-01-06 2021-01-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,689 11,311 -40.47 55.80 -429,028 631,127
2021-01-06 2021-01-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 19,000 19,000 1.89 35,910 35,910
2020-12-03 2020-12-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -19,000 45,354 -29.52
2020-12-03 2020-12-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -200 0 -100.00 62.94 -12,588
2020-12-03 2020-12-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,011 200 -83.48 61.87 -62,547 12,373
2020-12-03 2020-12-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -11,309 1,211 -90.33 61.16 -691,692 74,068
2020-12-03 2020-12-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,480 12,520 -34.11 60.23 -390,315 754,127
2020-12-03 2020-12-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 19,000 19,000 1.89 35,910 35,910
2020-11-06 2020-11-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -15,000 64,354 -18.90
2020-11-06 2020-11-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,831 0 -100.00 65.36 -185,034
2020-11-06 2020-11-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -12,169 2,831 -81.13 64.67 -786,953 183,077
2020-11-06 2020-11-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 15,000 15,000 1.89 28,350 28,350
2020-11-04 2020-11-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -23,315 79,354 -22.71
2020-11-04 2020-11-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,499 0 -100.00 58.53 -204,805
2020-11-04 2020-11-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -12,611 3,499 -78.28 57.74 -728,211 202,047
2020-11-04 2020-11-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,205 16,110 -30.90 57.03 -410,911 918,774
2020-11-04 2020-11-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 23,315 23,315 1.89 44,065 44,065
2020-10-05 2020-10-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -20,365 102,669 -16.55
2020-10-05 2020-10-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -104,635 0 -100.00
2020-10-05 2020-10-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -23,886 0 -100.00 51.98 -1,241,597
2020-10-05 2020-10-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -101,114 23,886 -80.89 51.52 -5,208,888 1,230,487
2020-10-05 2020-10-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 20,365 125,000 19.46 1.89 38,490 236,250
2020-10-05 2020-10-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 104,635 104,635 1.89 197,760 197,760
2020-07-17 2020-07-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		A - Award 723 723 34.58 25,001 25,001
2020-07-06 2020-07-06 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -27,544 104,635 -20.84
2020-07-06 2020-07-06 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -350 0 -100.00 57.13 -19,996
2020-07-06 2020-07-06 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,283 350 -92.45 56.55 -242,219 19,794
2020-07-06 2020-07-06 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,867 4,633 -59.71 55.52 -381,273 257,236
2020-07-06 2020-07-06 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -16,044 11,500 -58.25 54.69 -877,384 628,890
2020-07-06 2020-07-06 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 27,544 27,544 1.89 52,058 52,058
2020-07-06 2020-07-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -48,245 132,179 -26.74
2020-07-06 2020-07-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -800 0 -100.00 57.96 -46,366
2020-07-06 2020-07-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -37,100 800 -97.89 56.85 -2,109,128 45,480
2020-07-06 2020-07-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -10,345 37,900 -21.44 56.01 -579,471 2,122,953
2020-07-06 2020-07-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 48,245 48,245 1.89 91,183 91,183
2020-07-06 2020-07-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -49,211 180,424 -21.43
2020-07-06 2020-07-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -200 0 -100.00 60.58 -12,116
2020-07-06 2020-07-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -14,016 200 -98.59 59.97 -840,524 11,994
2020-07-06 2020-07-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,632 14,216 -37.78 59.02 -509,503 839,098
2020-07-06 2020-07-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -26,363 22,848 -53.57 58.22 -1,534,746 1,330,117
2020-07-06 2020-07-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 49,211 49,211 1.89 93,009 93,009
2020-06-12 2020-06-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		A - Award 12,000 12,000
2020-04-30 2020-04-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -25,000 229,635 -9.82
2020-04-30 2020-04-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,000 0 -100.00 58.00 -464,000
2020-04-30 2020-04-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,981 8,000 -33.23 56.96 -226,773 455,711
2020-04-30 2020-04-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -11,819 11,981 -49.66 56.31 -665,576 674,699
2020-04-30 2020-04-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,200 23,800 -4.80 55.12 -66,140 1,311,777
2020-04-30 2020-04-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 25,000 25,000 1.89 47,250 47,250
2020-04-21 2020-04-17 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -23,892 254,635 -8.58
2020-04-21 2020-04-17 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -23,892 0 -100.00 46.67 -1,115,150
2020-04-21 2020-04-17 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 23,892 23,892 1.89 45,156 45,156
2020-04-16 2020-04-14 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -1,108 278,527 -0.40
2020-04-16 2020-04-14 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,108 0 -100.00 46.71 -51,753
2020-04-16 2020-04-14 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 1,108 1,108 1.89 2,094 2,094
2020-04-03 2020-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -75,000 279,635 -21.15
2020-04-03 2020-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,166 0 -100.00 40.08 -86,813
2020-04-03 2020-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,480 2,166 -53.38 39.29 -97,439 85,102
2020-04-03 2020-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -11,672 4,646 -71.53 38.13 -445,053 177,152
2020-04-03 2020-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -58,682 16,318 -78.24 37.29 -2,188,252 608,498
2020-04-03 2020-04-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 75,000 75,000 1.89 141,750 141,750
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -31,422 354,635 -8.14
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,200 0 -100.00 58.69 -70,430
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,331 1,200 -85.93 58.08 -425,751 69,691
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -18,903 8,531 -68.90 57.21 -1,081,384 488,033
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,988 27,434 -12.69 56.01 -223,358 1,536,507
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 31,422 31,422 1.89 59,388 59,388
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -93,578 386,057 -19.51
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,034 0 -100.00 61.98 -64,088
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,000 1,034 -49.16 60.82 -60,819 62,887
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,731 2,034 -57.31 59.40 -162,229 120,825
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -33,045 4,765 -87.40 58.08 -1,919,300 276,758
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -55,768 37,810 -59.60 57.50 -3,206,677 2,174,086
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 93,578 93,578 1.89 176,862 176,862
2019-11-05 2019-11-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -7,500 479,635 -1.54
2019-11-05 2019-11-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,500 0 -100.00 45.02 -337,646
2019-11-05 2019-11-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 7,500 7,500 1.89 14,175 14,175
2019-09-13 2019-09-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -22,500 487,135 -4.41
2019-09-13 2019-09-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,151 0 -100.00 35.41 -217,789
2019-09-13 2019-09-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -16,349 6,151 -72.66 34.81 -569,043 214,092
2019-09-13 2019-09-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 22,500 22,500 1.89 42,525 42,525
2019-09-05 2019-09-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -7,500 509,635 -1.45
2019-09-05 2019-09-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,500 0 -100.00 36.26 -271,975
2019-09-05 2019-09-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 7,500 7,500 1.89 14,175 14,175
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -22,500 517,135 -4.17
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,000 0 -100.00 42.49 -169,978
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,300 4,000 -24.53 41.77 -54,303 167,087
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -13,767 5,300 -72.20 40.50 -557,558 214,648
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,433 19,067 -15.26 39.47 -135,502 752,582
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 22,500 22,500 1.89 42,525 42,525
2019-02-19 2019-02-19 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -3,997 539,635 -0.74
2019-02-19 2019-02-19 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,997 0 -100.00 30.00 -119,913
2019-02-19 2019-02-19 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 3,997 3,997 1.89 7,554 7,554
2019-02-19 2019-02-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -4,934 543,632 -0.90
2019-02-19 2019-02-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,934 0 -100.00 28.01 -138,193
2019-02-19 2019-02-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 4,934 4,934 1.89 9,325 9,325
2019-02-19 2019-02-14 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -500 548,566 -0.09
2019-02-19 2019-02-14 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 0 -100.00 28.00 -14,000
2019-02-19 2019-02-14 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 500 500 1.89 945 945
2019-02-14 2019-02-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -2,666 549,066 -0.48
2019-02-14 2019-02-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,666 0 -100.00 28.00 -74,657
2019-02-14 2019-02-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,666 2,666 1.89 5,039 5,039
2019-02-14 2019-02-12 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -200 551,732 -0.04
2019-02-14 2019-02-12 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -200 0 -100.00 28.00 -5,600
2019-02-14 2019-02-12 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 200 200 1.89 378 378
2019-02-07 2019-02-05 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -1,700 551,932 -0.31
2019-02-07 2019-02-05 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,700 0 -100.00 28.01 -47,611
2019-02-07 2019-02-05 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock 		M - Exercise 1,700 1,700 1.89 3,213 3,213
2019-02-01 2019-01-30 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		A - Award 263,000 263,000
2018-02-20 2018-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		A - Award 225,000 225,000
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise 247,633 247,633
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -43,829 0 -100.00
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise 217,525 217,525
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -38,500 0 -100.00
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise 553,632 553,632
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -97,988 0 -100.00
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise 123,034 123,034
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -21,776 0 -100.00
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)